IOVA vs AAPL: Which Stock is Better?
Side-by-side comparison of Iovance Biotherapeutics Inc and Apple Inc in 2026
IOVA
Iovance Biotherapeutics Inc
$3.64
AAPL
Apple Inc
$258.74
Key Metrics Comparison
| Metric | IOVA | AAPL | Winner |
|---|---|---|---|
| Market Cap | $1.43B | N/A | IOVA |
| P/E Ratio | N/A | 32.77 | AAPL |
| EPS (TTM) | $N/A | $7.91 | AAPL |
| Revenue Growth | 0.2% | 0.2% | IOVA |
| Gross Margin | 34.3% | 47.3% | AAPL |
Analyze IOVA
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IOVA or AAPL a better investment?
Comparing IOVA and AAPL: Iovance Biotherapeutics Inc has a market cap of $1.43B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IOVA and AAPL?
IOVA (Iovance Biotherapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IOVA or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IOVA or AAPL?
IOVA has higher revenue growth at 0.2% vs 0.2% for AAPL.
Which company is more profitable: IOVA or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to 34.3% for IOVA.
Which is the larger company: IOVA or AAPL?
Iovance Biotherapeutics Inc (IOVA) is larger with a market cap of $1.43B compared to N/A for AAPL.
Should I buy IOVA or AAPL in 2026?
Both IOVA and AAPL have investment merit. IOVA trades at $3.64 while AAPL trades at $258.74. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IOVA and AAPL stock?
Key differences: Market Cap ($1.43B vs N/A), P/E Ratio (N/A vs 32.8x), Revenue Growth (0.2% vs 0.2%), Gross Margin (34.3% vs 47.3%).